• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证一种新型蒙特利尔认知评估评分算法在非痴呆帕金森病患者中的应用。

Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.

机构信息

German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Otfried-Müller-Str. 23, 72076, Tübingen, Germany.

Hertie Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tübingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Germany.

出版信息

J Neurol. 2018 Sep;265(9):1976-1984. doi: 10.1007/s00415-018-8942-4. Epub 2018 Jun 23.

DOI:10.1007/s00415-018-8942-4
PMID:29936665
Abstract

INTRODUCTION

The early diagnosis of mild cognitive impairment (PD-MCI) in Parkinson's disease (PD) is essential as it increases the future risk for PD dementia (PDD). Recently, a novel weighting algorithm for the Montreal Cognitive Assessment (MoCA) subtests has been reported, to best discriminate between those with and without cognitive impairment in PD. The aim of our study was to validate this scoring algorithm in a large sample of non-demented PD patients, hypothesizing that the weighted MoCA would have a higher diagnostic accuracy for PD-MCI than the original MoCA.

METHODS

In 202 non-demented PD patients, we evaluated cognitive status, clinical and demographic data, as well as the MoCA with a weighted and unweighted score. Receiver operating characteristic (ROC) curve analysis was used to evaluate discriminative ability of the MoCA. Group comparisons and ROC analysis were performed for PD-MCI classifications with a cut-off ≤ 1, 1.5, and 2 standard deviation (SD) below appropriate norms.

RESULTS

PD-MCI patients scored lower on the weighted than the original MoCA version (p < 0.001) compared to PD patients with normal cognitive function. Areas under the curve only differed significantly for the 2 SD cut-off, leading to an increased sensitivity of the weighted MoCA score (72.9% vs. 70.5%) and specificity compared to the original version (79.0% vs. 65.4%).

CONCLUSIONS

Our results indicate better discriminant power for the weighted MoCA compared to the original for more advanced stages of PD-MCI (2 SD cut-off). Future studies are needed to evaluate the predictive value of the weighted MoCA for PDD.

摘要

简介

早期诊断帕金森病(PD)患者的轻度认知障碍(PD-MCI)至关重要,因为它会增加 PD 痴呆(PDD)的未来风险。最近,一种蒙特利尔认知评估(MoCA)子测试的新型加权算法已被报道,可最佳区分 PD 患者有无认知障碍。我们的研究旨在在大量非痴呆 PD 患者中验证该评分算法,假设加权 MoCA 对 PD-MCI 的诊断准确性高于原始 MoCA。

方法

在 202 名非痴呆 PD 患者中,我们评估了认知状态、临床和人口统计学数据,以及加权和非加权 MoCA 评分。使用接收者操作特征(ROC)曲线分析评估 MoCA 的区分能力。使用≤1、1.5 和 2 个标准差(SD)低于适当标准的截断值,对 PD-MCI 分类进行组间比较和 ROC 分析。

结果

与认知功能正常的 PD 患者相比,PD-MCI 患者的加权 MoCA 评分低于原始 MoCA 版本(p<0.001)。曲线下面积仅在 2 SD 截断值上有显著差异,导致加权 MoCA 评分的敏感性(72.9%比 70.5%)和特异性(79.0%比 65.4%)较原始版本增加。

结论

与原始 MoCA 相比,加权 MoCA 在更晚期的 PD-MCI(2 SD 截断值)下具有更好的区分能力。未来需要研究评估加权 MoCA 对 PDD 的预测价值。

相似文献

1
Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.验证一种新型蒙特利尔认知评估评分算法在非痴呆帕金森病患者中的应用。
J Neurol. 2018 Sep;265(9):1976-1984. doi: 10.1007/s00415-018-8942-4. Epub 2018 Jun 23.
2
Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.帕金森病认知障碍的筛查:通过子测验加权提高蒙特利尔认知评估量表(MoCA)的诊断效用
PLoS One. 2016 Jul 20;11(7):e0159318. doi: 10.1371/journal.pone.0159318. eCollection 2016.
3
Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.帕金森病患者中蒙特利尔认知评估量表(MoCA-P)波斯语版本的有效性和可靠性。
Appl Neuropsychol Adult. 2020 Sep-Oct;27(5):431-439. doi: 10.1080/23279095.2019.1565762. Epub 2019 Mar 1.
4
Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.蒙特利尔认知评估量表、简易精神状态检查和 SCOPA-Cog 在非痴呆帕金森病患者中的变化反应性。
Dement Geriatr Cogn Disord. 2019;47(4-6):187-197. doi: 10.1159/000496454. Epub 2019 Jul 17.
5
Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.认知特征及常规认知测试在老年帕金森病、帕金森病痴呆、阿尔茨海默病及认知正常个体中的最佳截断值。
Psychogeriatrics. 2020 Jan;20(1):20-27. doi: 10.1111/psyg.12451. Epub 2019 Mar 25.
6
Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.蒙特利尔认知评估用于早期帕金森病认知功能下降的筛查和预测。
Parkinsonism Relat Disord. 2014 Nov;20(11):1145-8. doi: 10.1016/j.parkreldis.2014.08.002. Epub 2014 Aug 14.
7
Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.验证蒙特利尔认知评估量表(MoCA-TR)土耳其语版本在帕金森病患者中的应用。
Clin Neuropsychol. 2014;28(2):333-43. doi: 10.1080/13854046.2014.881554. Epub 2014 Feb 17.
8
Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic.在澳大利亚老年病诊所中,快速轻度认知障碍(Qmci)筛查与蒙特利尔认知评估(MoCA)的比较。
Int J Geriatr Psychiatry. 2017 Jun;32(6):643-649. doi: 10.1002/gps.4505. Epub 2016 Jul 18.
9
Rapid communication: Preliminary validation of a telephone adapted Montreal Cognitive Assessment for the identification of mild cognitive impairment in Parkinson's disease.快速通讯:电话改编的蒙特利尔认知评估用于识别帕金森病轻度认知障碍的初步验证。
Clin Neuropsychol. 2021 Jan;35(1):133-147. doi: 10.1080/13854046.2020.1801848. Epub 2020 Aug 11.
10
MACE versus MoCA: equivalence or superiority? Pragmatic diagnostic test accuracy study.MACE 与 MoCA:等效还是优越?实用诊断测试准确性研究。
Int Psychogeriatr. 2017 Jun;29(6):931-937. doi: 10.1017/S1041610216002210. Epub 2017 Mar 7.

引用本文的文献

1
Network relationship between cognitive function and quality of life in community-dwelling older adults: an observational study from Beijing.社区居住老年人认知功能与生活质量的网络关系:一项来自北京的观察性研究
Front Public Health. 2025 Feb 7;12:1516895. doi: 10.3389/fpubh.2024.1516895. eCollection 2024.
2
German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson's disease: new spotlights on diagnostic procedures and non-pharmacological interventions.德国神经病学会关于帕金森病患者认知障碍和情感障碍的诊断和治疗指南:诊断程序和非药物干预的新重点。
J Neurol. 2024 Nov;271(11):7330-7357. doi: 10.1007/s00415-024-12503-0. Epub 2024 Aug 9.
3

本文引用的文献

1
Clinical milestones in Parkinson's disease: A 7-year population-based incident cohort study.帕金森病的临床里程碑:一项基于人群的 7 年发病队列研究。
Parkinsonism Relat Disord. 2017 Sep;42:28-33. doi: 10.1016/j.parkreldis.2017.05.025. Epub 2017 May 29.
2
Diagnostic Accuracy and Confidence in the Clinical Detection of Cognitive Impairment in Early-Stage Parkinson Disease.早期帕金森病认知障碍临床检测中的诊断准确性与信心
J Geriatr Psychiatry Neurol. 2017 May;30(3):178-183. doi: 10.1177/0891988717701001. Epub 2017 Mar 28.
3
Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.
NIMHANS Neuropsychological Battery for Elderly in Parkinson's Disease Patients: Validation and Diagnosis using MDS PD-MCI Task Force Criteria in Indian Population.
用于帕金森病患者的NIMHANS老年神经心理成套测验:基于MDS帕金森病轻度认知障碍工作组标准在印度人群中的验证与诊断
Ann Indian Acad Neurol. 2023 May-Jun;26(3):247-255. doi: 10.4103/aian.aian_903_22. Epub 2023 Apr 28.
4
Acute changes in systemic glycemia gate access and action of GLP-1R agonist on brain structures controlling energy homeostasis.急性系统血糖变化对 GLP-1R 激动剂作用于控制能量平衡的脑结构的影响。
Cell Rep. 2022 Nov 22;41(8):111698. doi: 10.1016/j.celrep.2022.111698.
新诊断帕金森病中轻度认知障碍的稳定性
J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):648-652. doi: 10.1136/jnnp-2016-315099. Epub 2017 Mar 1.
4
Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.帕金森病认知障碍的筛查:通过子测验加权提高蒙特利尔认知评估量表(MoCA)的诊断效用
PLoS One. 2016 Jul 20;11(7):e0159318. doi: 10.1371/journal.pone.0159318. eCollection 2016.
5
Predictors of dementia in Parkinson disease: a prospective cohort study.帕金森病痴呆的预测因素:一项前瞻性队列研究。
Neurology. 2014 Sep 30;83(14):1253-60. doi: 10.1212/WNL.0000000000000842. Epub 2014 Aug 29.
6
Executive dysfunction in Parkinson's disease: a review.帕金森病的执行功能障碍:综述。
J Neuropsychol. 2013 Sep;7(2):193-224. doi: 10.1111/jnp.12028.
7
Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.早期帕金森病患者轻度认知障碍的预后:挪威 ParkWest 研究。
JAMA Neurol. 2013 May;70(5):580-6. doi: 10.1001/jamaneurol.2013.2110.
8
Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden.帕金森病患者的认知障碍:对生活质量、残疾和照顾者负担的影响。
J Geriatr Psychiatry Neurol. 2012 Dec;25(4):208-14. doi: 10.1177/0891988712464823. Epub 2012 Nov 21.
9
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.帕金森病轻度认知障碍的诊断标准:运动障碍学会工作组指南。
Mov Disord. 2012 Mar;27(3):349-56. doi: 10.1002/mds.24893. Epub 2012 Jan 24.
10
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.MDS 工作组关于帕金森病轻度认知障碍:对 PD-MCI 的批判性回顾。
Mov Disord. 2011 Aug 15;26(10):1814-24. doi: 10.1002/mds.23823. Epub 2011 Jun 9.